Vertex Pharmaceuticals
Edit

Vertex Pharmaceuticals

https://www.vrtx.com/
Last activity: 27.04.2024
Categories: BioTechBusinessCauseCorporateDevelopmentHealthTechMedtechResearchScienceSociety
Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious and life-threatening diseases. We discovered and developed the first medicines to treat the underlying cause of cystic fibrosis (CF), a rare, life-threatening genetic disease. In addition to clinical development programs in CF, Vertex has more than a dozen ongoing research programs focused on the underlying mechanisms of other serious diseases. Founded in 1989 in Cambridge, Massachusetts, our corporate headquarters is now located in Boston’s Innovation District, and our international headquarters is in London, United Kingdom. We currently employ approximately 3,500 people in the United States, Europe, Canada, Australia and Latin America with nearly two-thirds of our staff dedicated to research and development. Vertex is consistently recognized as one of the industry’s top places to work by Science Magazine, The Boston Globe, Boston Business Journal and the San Diego Business Journal. Our research and medicines have also received esteemed recognitions, including the Robert J. Beall Therapeutics Development Award, the French Prix Galien and the British Pharmacological Society awards.
Followers
176.16K
Website visits
108.7K /mo.
Mentions
46
Location: United States, Massachusetts, Boston
Employees: 1001-5000
Total raised: $480K
Founded date: 1989

Investors 2

Funding Rounds 1

DateSeriesAmountInvestors
19.10.2022-$480K-

Mentions in press and media 46

DateTitleDescriptionSource
27.04.2024India becoming attractive for clinical trials, says pharma i...-business-s...
24.04.2024Govt expands committee for drugs, medical devices pricing re...-business-s...
23.04.2024VERTEX AND TREEFROG THERAPEUTICS ANNOUNCE LICENSING AGREEMEN...Vertex obtains an exclusive license to TreeFrog's C-StemTM manufacturing technology in type 1 diabet...en.prnasia...
15.04.2024Women of Influence: Health Care 2024 – Ileana Hernandez-labusiness...
14.03.202410 прорывных разработок 2024 года по версии MIT Technology R...Источник: MIT Technology Review Начиная с 2001 года журнал Массачусетского технологического институт...habr.com/r...
13.03.2024После вмешательства генпрокурора РФ 68 южноуральцев обеспече...-kommersant...
12.01.2024CRISPR advances Sickle Cell disease treatmentThe innovative gene-editing technique, CRISPR, has made a remarkable leap from laboratory research t...readwrite....
17.11.2023Green light for world’s first CRISPR gene-edited therapystartuptic...
03.11.2023State Prescription Drug Affordability Boards could end up li...I was living on the precipice of end-stage disease when I enrolled in the clinical trial that result...statnews.c...
28.03.2023Up to $230 million for CRISPR Therapeuticsstartuptic...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In